000 01414cam a22004457a 4500
001 22290635
003 OSt
005 20250901142246.0
008 211029s2020 enk b 001 0 eng c
010 _a 2021277067
015 _aGBB9F8156
_2bnb
016 7 _a101761874
_2DNLM
016 7 _a019545233
_2Uk
020 _a9780128158494
035 _a22290635
035 _a(OCoLC)1107336088
040 _aNLM
_beng
_cNLM
_dBDX
_dUKMGB
_dOCLCF
_dYDX
_dLTSCA
_dOCLCO
_dOCLCQ
_dOCLCA
_dDLC
042 _apcc
050 0 0 _aRM301.9
_b.D37 2020
060 0 0 _a2020 A-854
060 1 0 _aWB 330
100 1 _aDasgupta, Amitava,
245 1 0 _aTherapeutic drug monitoring data :
250 _a4th ed.
260 _aLondon, United Kingdom ;
_aSan Diego, CA :
_bAcademic Press,
_c©2020.
300 _axi, 370 pages ;
_c23 cm
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
504 _aIncludes bibliographical references and index.
650 0 _aDrug monitoring.
650 1 2 _aDrug Monitoring.
650 2 2 _aPharmaceutical Preparations.
650 7 _aDrug monitoring.
_2fast
_0(OCoLC)fst00898688
700 1 _aKrasowski, Matthew D.
776 0 8 _iEbook version :
_z9780128158500
906 _a7
_bcbc
_cpccadap
_d2
_encip
_f20
_gy-gencatlg
942 _2lcc
_cBK
999 _c2873
_d2873